Short-term outcomes of ovarian vein embolization with adjunctive local sclerotherapy in patients with pelvic venous disorder and vulvar varicosities: a single-center retrospective experience - Scorecard - MDSpire
Advertisement
Short-term outcomes of ovarian vein embolization with adjunctive local sclerotherapy in patients with pelvic venous disorder and vulvar varicosities: a single-center retrospective experience
Clinical Scorecard: Outcomes of Ovarian Vein Embolization Combined with Local Sclerotherapy in Women with Pelvic Venous Disorder and Vulvar Varicosities: A Retrospective Analysis from a Single Center
At a Glance
Category
Detail
Condition
Pelvic Venous Disorder (PeVD)
Key Mechanisms
Ovarian vein embolization and local sclerotherapy for symptomatic vulvar/external genital varicosities.
Target Population
Women with pelvic venous disorder presenting with vulvar/external genital varicosities.
Care Setting
Single-center retrospective analysis.
Key Highlights
Technical success achieved in all patients.
Mean VAS decreased from 5.8 to 0.9 post-treatment.
Mean PVCSS decreased from 10.7 to 4.0 post-treatment.
Complete symptom relief in 56% of patients.
No major procedure-related adverse events observed.
Guideline-Based Recommendations
Diagnosis
Clinical assessment includes symptom evaluation, VAS, and PVCSS.
Management
Ovarian vein embolization followed by local sclerotherapy.
Monitoring & Follow-up
Follow-up imaging and symptom evaluation at median 7 months.
Risks
No major procedure-related adverse events reported.
Patient & Prescribing Data
16 women treated for PeVD with vulvar/external genital varicosities.
Adjunctive local sclerotherapy enhances symptom relief.
Clinical Best Practices
Utilize a transfemoral venous approach under fluoroscopic guidance for procedures.
Conduct thorough preprocedural imaging to assess venous anatomy.
A JAMA Internal Medicine Viewpoint urges clinicians and health systems to verify risk-model inputs before acting on automated breast cancer screening recommendations.
